This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genentech, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael C Wei: Innovator in Bispecific Antibody Treatments
Introduction
Michael C Wei is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments using bispecific antibodies. His work is instrumental in advancing therapeutic options for various diseases.
Latest Patents
Michael C Wei holds a patent titled "Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates." This patent reflects his commitment to improving treatment methodologies and enhancing patient outcomes through targeted therapies. He has 1 patent to his name, showcasing his innovative approach in the field.
Career Highlights
Wei is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing medicines for serious medical conditions. His role at Genentech allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Throughout his career, Michael has worked alongside talented colleagues, including Klara Totpal and Brendan Christian Bender. These collaborations have fostered an environment of innovation and creativity, leading to advancements in therapeutic strategies.
Conclusion
Michael C Wei exemplifies the spirit of innovation in the biotechnology sector. His contributions to bispecific antibody treatments are paving the way for new therapeutic possibilities. His work continues to inspire future advancements in medical science.